Life (Sep 2021)

Declining Mortality Rate of Hospitalised Patients in the Second Wave of the COVID-19 Epidemics in Italy: Risk Factors and the Age-Specific Patterns

  • Antonella D’Arminio Monforte,
  • Alessandro Tavelli,
  • Francesca Bai,
  • Daniele Tomasoni,
  • Camilla Falcinella,
  • Roberto Castoldi,
  • Diletta Barbanotti,
  • Giovanni Mulè,
  • Marina Allegrini,
  • Elisa Suardi,
  • Daniele Tesoro,
  • Gianmarco Tagliaferri,
  • Debora Mondatore,
  • Matteo Augello,
  • Andrea Cona,
  • Tomaso Beringheli,
  • Nicole Gemignani,
  • Matteo Sala,
  • Benedetta Varisco,
  • Francesco Molà,
  • Sofia Pettenuzzo,
  • Lorenzo Biasioli,
  • Alessandro Copes,
  • Lidia Gazzola,
  • Ottavia Viganò,
  • Camilla Tincati,
  • Anna De Bona,
  • Teresa Bini,
  • Giulia Marchetti

DOI
https://doi.org/10.3390/life11090979
Journal volume & issue
Vol. 11, no. 9
p. 979

Abstract

Read online

Background: Mortality rate from COVID-19 in Italy is among the world’s highest. We aimed to ascertain whether there was any reduction of in-hospital mortality in patients hospitalised for COVID-19 in the second-wave period (October 2020–January 2021) compared to the first one (February–May 2020); further, we verified whether there were clusters of hospitalised patients who particularly benefitted from reduced mortality rate. Methods: Data collected related to in-patients’ demographics, clinical, laboratory, therapies and outcome. Primary end-point was time to in-hospital death. Factors associated were evaluated by uni- and multivariable analyses. A flow diagram was created to determine the rate of in-hospital death according to individual and disease characteristics. Results: A total of 1561 patients were included. The 14-day cumulative incidence of in-hospital death by competing risk regression was of 24.8% (95% CI: 21.3–28.5) and 15.9% (95% CI: 13.7–18.2) in the first and second wave. We observed that the highest relative reduction of death from first to second wave (more than 47%) occurred mainly in the clusters of patients younger than 70 years. Conclusions: Progress in care and supporting therapies did affect population over 70 years to a lesser extent. Preventive and vaccination campaigns should focus on individuals whose risk of death from COVID-19 remains high.

Keywords